RareSearch

8.7

Excellent

376 reviews

Communication: 8.8

Timeliness: 8.9

Accuracy: 7.6

Staff: 8.8

Value: 8.9

Lonnie McDermott

🇮🇹 Italy

9.1

Reviewed: August 11, 2023

- Clinical Data Management
- 6 weeks June - July 2023
- CRO

Timely and accurate data management, great collaboration.

The data management services were delivered on time and with great accuracy. Collaboration with the team was smooth, and they were always available to address any concerns or questions we had. We were very satisfied with the outcome.

Betty Hermann

🇨🇦 Canada

8.9

Reviewed: March 3, 2023

- Regulatory Submission
- 6 weeks February 2023
- Biotech Startup

Professional and knowledgeable, seamless regulatory submission process.

Our regulatory submission was handled with great care and expertise. The process was seamless, and their knowledge of the regulatory landscape was impressive. The team's support was invaluable, and I would not hesitate to use their services again.

Gene Upton-O'Keefe

🇨🇭 Switzerland

5.7

Reviewed: June 10, 2024

- Project Management
- 12 weeks March - May 2024
- Biotech Company

Poor communication and missed deadlines caused frustration.

Communication from the project management team was poor, with frequent missed deadlines. This caused significant frustration on our end, as we had to repeatedly chase them for updates. The project eventually got back on track, but the delays were problematic.

Lawrence Denesik

🇰🇷 South Korea

Reviewed: June 18, 2023

- Clinical Protocol Design
- 6 weeks April - May 2023
- Pharmaceutical Company

Comprehensive protocol design, very detailed and precise.

The protocol design provided was comprehensive and very detailed. It laid a strong foundation for our clinical trial, ensuring that all regulatory and ethical considerations were addressed. The attention to detail was impressive.

Troy Carter

🇫🇷 France

6.3

Reviewed: November 7, 2024

- Stability Studies
- 16 months July 2023 - November 2024
- Pharmaceutical Company

Stability studies lacked detail, required additional validation.

The stability studies conducted were lacking in detail, and we had to perform additional validation to ensure the results were reliable. This added extra time and cost to the project. The team was responsive to feedback, but the initial work was subpar.

Antoinette Crooks

🇹🇷 Turkey

5.8

Reviewed: April 5, 2024

- Biostatistical Design
- 6 weeks February - March 2024
- Research Institution

Biostatistical analysis lacked depth, missed key insights.

The biostatistical analysis provided was not as thorough as we had hoped. Some key insights were missed, and we had to engage another provider to get the level of detail we needed. The team seemed overworked and under-resourced.